Viking Therapeutics (VKTX) Gains as Patients Lose Weight

Viking Therapeutics (VKTX) soars on weight loss drug trials. Renita Young discusses this as 88% of patients tested achieved at least 10% weight loss. Tune in to find out more about the stock market today.

Morning Trade Live

27 Feb 2024

SHARE

Schwab Network's Newsletters

Daily insights for every investor